Detection rate (DR) of cervical carcinoma <i>in situ</i> or worse (CIS+) in screening participants aged 30 years and over, stratified by age group and health insurance status, the Korean organized cancer screening program, 2005–2006.

<p>aOR, adjusted odds ratio; CIS: carcinoma <i>in situ</i>; CI, confidence interval; ICC: invasive cervical cancer; MAP, Medical Aid Program; NHI, National Health Insurance.</p>a<p>aOR is adjusted for variables in the table.</p

Percent distribution of Pap test results by age group and health insurance status in the Korean organized cancer screening program, 2005–2006.

<p>MAP, Medical Aid Program; NHI, National Health Insurance.</p>a<p>including suspicious and highly suggestive of malignancy.</p

Interval cancer rates (ICR) of cervical cancer in screening participants aged 30 years and over, stratified by age group and health insurance status, the Korean organized cancer screening program, 2005–2006.

<p>aOR, Adjusted odds ratio; CI, confidence interval; MAP, Medical Aid Program; NHI, National Health Insurance.</p>a<p>per 1,000 negative screenings.</p>b<p>aOR is adjusted for variables in the table.</p

Sensitivity (sen) and specificity (spe) for detecting of cervical cancer by age group and health insurance status, the Korean organized cancer screening program, 2005–2006.

<p>CIS: carcinoma <i>in situ</i>; CI, confidence interval; ICC: invasive cervical cancer; MAP, Medical Aid Program; NHI, National Health Insurance.</p

Percentage of carcinoma <i>in situ</i> (CIS) cases among screen detected CIS+ by age and health insurance, the Korean organized cancer screening program, 2005–2006.

<p>aOR, adjusted odds ratio; CI, confidence interval; MAP, Medical Aid Program; NHI, National Health Insurance.</p>a<p>Including CIS and invasive cervical cancer.</p>b<p>aORs adjusted for variables in the table.</p

Characteristics of 2,250,392 participants who underwent UGIS or endoscopy screening through the NCSP for gastric cancer, 2002–2005.

<p>UGIS, upper-gastrointestinal series; NCSP, National Cancer Screening Program; NHI, national health insurance.</p>a<p>All differences between participants who underwent UGIS screening and those who underwent endoscopy screening were statistically significant (<i>p</i><0.001).</p

Positivity rate for gastric cancer by screening method, NCSP for gastric cancer, 2002–2005.

<p>UGIS, upper-gastrointestinal series; CI, confidence interval; NHI, national health insurance.</p

Diagram of gastric cancer screening in the NCSP.

<p>Diagram of gastric cancer screening in the NCSP.</p

Sensitivity, specificity, and PPVs for detecting gastric cancer by screening method, NCSP for gastric cancer, 2002–2005.

<p>PPV, positive predictive value; UGIS, upper-gastrointestinal series; CI, confidence interval; NHI, national health insurance.</p

Detection rate and ICR for gastric cancer by screening method, NCSP for gastric cancer, 2002–2005.

<p>ICR, interval cancer rate; UGIS, upper-gastrointestinal series; CI, confidence interval; NHI, national health insurance.</p